Venus files patent application for anti-bacterial drug

MUMBAI: Pharmaceutical firm Venus Remedies on Monday said it has filed a patent application for its combination drug for the treatment of multi-bacterial infections in children.

The company has filed its seventh patent application with the Indian Patent Office for its novel treatment developed at Venus Medicine Research Centre, Venus Remedies said in a filing to the Bombay Stock Exchange.

The formulation is a fixed dose combination of a latest generation Carbapenem and Amino-glycoside and would be the best available solution for treatment of multi-bacterial infections in Neo-Natals (new born babies) and children.

The company also said the drug is highly effective against the Cephalosporin Resistant Gram Negative Aerobic Bacilli as well as the Penicillin resistant pneumonococci, including Enterobacteria species, Klebsiella pneumoniae, Pseudomonas aeruginosa, Streptococcus pneurnoniee, MRSA, Haemophllus influenzae, Neisseria meningitides (meningococcus) and treatment of infections in immuno-compromised patients.

According to WHO estimates, one in three infant deaths worldwide occur due to Pneumonia (around 13 million each year) and the mortality rate in Bacterial Meningitis is about 20 per cent in children.

Shares of the company were trading at Rs 404 in afternoon, down 1.74 per cent on the BSE.